NCB grills health staff in Amritsar tramadol racket
Narcotics Control Bureau investigates two Punjab Health Department employees for alleged involvement in illegal tramadol distribution network. Shocking revelations emerge during interrogation.
Category : Search result: pharmaceutical firms
CDSCO flags 112 drugs, spurious cough syrup after child deaths
India's drug regulator CDSCO has flagged 112 medicines for quality violations and issued a nationwide alert about a spurious cough syrup following child fatalities in Madhya Pradesh. Critical safety update for consumers.
Dr. Reddy's Legacy: Transforming Indian Pharma
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
Dr. Reddy's Q2 Earnings Beat Estimates, Revenue Rises
Dr. Reddy's Laboratories delivers stellar Q2 FY25 results, beating revenue and profit forecasts. Discover how their pharmaceutical business and nicotine replacement portfolio drove exceptional performance.
FDA Recalls 140K+ Cholesterol Drug Bottles
Critical medication alert: Major pharmaceutical recall announced after FDA testing reveals cholesterol-lowering pills may not dissolve properly, potentially compromising effectiveness.
UP Drug Crackdown: Yogi Orders System Overhaul
In a major healthcare reform, Uttar Pradesh Chief Minister Yogi Adityanath mandates complete digitalization of drug regulation system and stricter quality control measures to ensure medicine safety across the state.
Elon Musk slams advisory firms opposing $1T pay package
Tesla CEO Elon Musk launches scathing attack on advisory firms ISS and Glass Lewis for opposing his massive compensation package. Musk defends his record and warns against 'extremely destructive' corporate advice.
Bangladeshi generic drug slashes rare disease treatment cost by 96%
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Sigachi Q2: Profit Halves, Revenue Down 19%
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
Cipla Shares Fall 3% Despite Eli Lilly Weight Loss Drug Deal
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Consulting Giants Wage War for IIM AI Talent
As AI transforms business, consulting giants Accenture, McKinsey, BCG, and Bain are aggressively hiring IIM graduates with AI expertise. Discover how Accenture is outpacing rivals in this high-stakes talent battle.
Delhi HC Stays NPPA's ORS Branding Ban - Relief for Manufacturers
Delhi High Court puts temporary stay on NPPA's order restricting 'ORS' branding for manufacturers. JJ Arm and other companies get breathing room in crucial rehydration market.
India Pushes for Domestic Audit Giants to Rival Big Four
Indian government launches strategic push to create domestic audit powerhouses through global partnerships, aiming to reduce reliance on international firms and boost local expertise in financial oversight.
Aurobindo Pharma Expands to Chile with New Subsidiary
Indian pharma giant Aurobindo Pharma establishes new subsidiary in Chile, marking strategic expansion across South American markets with focus on branded prescriptions and over-the-counter medicines.
Drug kingpin arrested in Mumbai after ₹252 crore seizure
Mumbai Crime Branch arrests wanted drug smuggler Lalit Patil after massive nationwide manhunt in connection with record ₹252 crore pharmaceutical drug seizure case.
Chandigarh Pharma Quality Summit Sets New Standards
Leading pharmaceutical experts gathered in Chandigarh for a crucial conference on drug quality and regulatory compliance, focusing on improving manufacturing practices and patient safety across India.
Torrent Pharma gets CCI nod for JB Chemicals stake
In a major pharmaceutical industry move, Torrent Pharmaceuticals receives Competition Commission of India approval to acquire controlling stake in JB Chemicals & Pharmaceuticals, marking significant consolidation in Indian pharma sector.
Indian Pharma Wins Crucial Legal Battle for Generic Drugs
A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.
Tesla Chair Defends Elon Musk's $1T Pay Package
Tesla's board chairman Robyn Denholm defends Elon Musk's historic compensation package, slamming proxy advisory firms' recommendations as flawed in powerful shareholder letter.
Biocon's US Insulin Move with Civica Partnership
Indian pharmaceutical leader Biocon Biologics partners with Civica to disrupt US insulin market with affordable alternatives, while also eyeing anti-obesity therapy opportunities.
BCI Clarifies Foreign Law Firm Collaboration Rules
The Bar Council of India clarifies its stance on foreign law firm collaborations after retracting an earlier press release, maintaining that current regulations prohibit such partnerships without explicit permission.
WHO: India's cough syrup safety still concerning
World Health Organization reports India making progress on drug regulation but warns more action needed to prevent toxic cough syrup incidents that have claimed lives globally.
Nigerian Drug Cartels Recruit Indian Pharma Students: Delhi Police
Delhi Police uncovers how Nigerian drug cartels are recruiting Indian students from pharma colleges, providing specialized training, and creating sophisticated dispatch systems to smuggle narcotics globally.
Zydus vs Rubicon: Pharma Stock Analysis
Expert analysis compares Zydus Lifesciences and Rubicon Research in the booming Indian pharmaceutical sector. Discover key financial metrics, growth drivers, and investment outlook for these promising stocks.
Indian Pharma Q2 Preview: Steady Growth Amid Challenges
India's pharmaceutical sector gears up for Q2 FY25 with projected 5-7% revenue growth, navigating US pricing pressures and domestic GST reductions while maintaining stable profitability.
UP seizes ₹3 crore banned cough syrup in major drug bust
Uttar Pradesh authorities intercept massive consignment of prohibited cough syrup worth ₹3 crore in ongoing war against illegal pharmaceutical trade.
UP seizes ₹3 crore cough syrup in major drug bust
Massive drug crackdown in Uttar Pradesh as officials confiscate illegal cough syrup worth ₹3 crore from a Sonbhadra warehouse. Investigation reveals sophisticated smuggling operation.
Biocon chief denies Karnataka deputy CM's allegations
Biocon Executive Chairperson Kiran Mazumdar-Shaw firmly denies Karnataka Deputy CM DK Shivakumar's claims about the company's Bengaluru expansion plans, asserting their commitment to the state is unwavering.
India's New Prescription for Children's Cough Syrups
Discover how India is transforming its approach to pediatric cough syrups with new regulations, bitter-tasting alternatives, and enhanced safety measures following global health concerns.
MP SIT to Make More Arrests in Pharma Tragedy
Madhya Pradesh's Special Investigation Team gears up for significant arrests in the Sresan Pharma cough syrup case that claimed young lives. Exclusive details on the expanding investigation.
Page 4 of 4